However, GSEA (RRID: SCR_003199) revealed differences between the PDX and clinical tumor in some gene sets related to angiogenesis, epithelial–mesenchymal transition and KRAS-up signaling (Supplementary Fig. S4C). This evidence concerns the gene KRAS and neoplasm.